Modifying and improving clinical understanding of homoeopathic remedies through successful management of Essential Hypertension with homeopathic drugs: an uncontrolled experimental study

Evolving clinical Materia Medica of commonly indicated remedies through standardized homoeopathic management strategies of clinical cases of Essential Hypertension: An Experimental Uncontrolled Study. - NIL

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/066236

Enrollment

196

Registered

2024-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Homoeopathic indicated Remedy: Indicated homeopathic remedy will be prescribed for the management of Essential Hypertension Intervention2: Indicated homeopathic remedy.: Indicated homeo

Eligibility

Inclusion criteria

Inclusion criteria: 1) Diagnosed as per international society of hypertension 2) All stages of Essential hypertension 3) Essential hypertension with and without end organ complications 4) all genders 5) patient taking antihypertensive therapy with no changes in the drug regimen during the course of study 6) Patient without antihypertensive therapy 7) patient with controlled and uncontrolled hypertennsion

Exclusion criteria

Exclusion criteria: 1) Pregnancy induced hypertension 2) Patient with secondary hypertension 3) Patient suffering with Cancer and other autoimmune disorders

Design outcomes

Primary

Measure	Time frame
1) studying the prevalence of different stages of essential hypertension in enrolled sample size 2) Studying the gender prevalence of Ess Hypertension in enrolled sample size 3) Studying the prevalence of end organ complications of Ess hypertension in hypertensive population of calculated sample 4) to study the effect of homoeopathic remedy in the controlling and reducing the high blood pressure and subjective distress. Timepoint: 1) BP measurement and subjective distress will be noted before starting with homoeopathic intervention (at baseline) 2) After that BP measurement will be done weekly or fortnightly as per need of individual case 3) to assess improvement modified Naranjo criteria will be applied at the beginning, and then every monthly.	—

Measure

Time frame

1) studying the prevalence of different stages of essential hypertension in enrolled sample size 2) Studying the gender prevalence of Ess Hypertension in enrolled sample size 3) Studying the prevalence of end organ complications of Ess hypertension in hypertensive population of calculated sample 4) to study the effect of homoeopathic remedy in the controlling and reducing the high blood pressure and subjective distress. Timepoint: 1) BP measurement and subjective distress will be noted before starting with homoeopathic intervention (at baseline) 2) After that BP measurement will be done weekly or fortnightly as per need of individual case 3) to assess improvement modified Naranjo criteria will be applied at the beginning, and then every monthly.

—

Secondary

Measure	Time frame
1) to study the various evolutions,presentations,and clinicopathological correlations in acute and chronic stages of essential hypertension and its correlation with susceptibility and miasm.Timepoint: 3 years	—

Countries

India

Contacts

Public ContactDr Harshla C Sarvagod

Dr M L Dhawale Memorial Homoeopathic Institute

drjainbipin@gmail.com9323690095

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026